| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2022-03-07 02:51:51 UTC |
|---|
| HMDB ID | HMDB0015096 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Mepivacaine |
|---|
| Description | Mepivacaine, also known as carbocaine or carboplyin dental, belongs to the class of organic compounds known as piperidinecarboxamides. Piperidinecarboxamides are compounds containing a piperidine ring substituted with a carboxamide functional group. Mepivacaine is a drug which is used for production of local or regional analgesia and anesthesia by local infiltration, peripheral nerve block techniques, and central neural techniques including epidural and caudal blocks. In humans, mepivacaine is involved in the mepivacaine action pathway. Mepivacaine is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on Mepivacaine. |
|---|
| Structure | CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C InChI=1S/C15H22N2O/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18) |
|---|
| Synonyms | | Value | Source |
|---|
| (+-)-1-Methyl-2',6'-pipecoloxylidide | ChEBI | | 1-Methyl-2',6'-pipecoloxylidide | ChEBI | | Carbocaine | ChEBI | | DL-Mepivacaine | ChEBI | | Mepivacaina | ChEBI | | Mepivacainum | ChEBI | | N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide | ChEBI | | N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide | ChEBI | | Carboplyin dental | Kegg | | Mepivacaine HCL | HMDB | | Mepivacaine hydrochloride | HMDB | | Mepivicaine | HMDB | | S-Ropivacaine mesylate | HMDB | | 3m Brand OF mepivacaine hydrochloride | HMDB | | AstraZeneca brand OF mepivacaine hydrochloride | HMDB | | Inibsa brand OF mepivacaine hydrochloride | HMDB | | Isogaine | HMDB | | Mepivacain injektopas | HMDB | | Mepivacaina braun | HMDB | | Monohydrochloride, mepivacaine | HMDB | | Pascoe brand OF mepivacaine hydrochloride | HMDB | | Scandicaine | HMDB | | Astra brand OF mepivacaine hydrochloride | HMDB | | Hexal brand OF mepivacaine hydrochloride | HMDB | | Hydrochloride, mepivacaine | HMDB | | Mepihexal | HMDB | | Mepivastesin | HMDB | | Novocol brand OF mepivacaine hydrochloride | HMDB | | Polocaine | HMDB | | Curasan brand OF mepivacaine hydrochloride | HMDB | | Abbott brand OF mepivacaine hydrochloride | HMDB | | Braun, mepivacaina | HMDB | | Clarben brand OF mepivacaine hydrochloride | HMDB | | Dentsply brand OF mepivacaine hydrochloride | HMDB | | Meaverin | HMDB | | Mecain | HMDB | | Sanofi brand OF mepivacaine hydrochloride | HMDB | | Scandinibsa | HMDB | | Aventis brand OF mepivacaine hydrochloride | HMDB | | Braun brand OF mepivicaine hydrochloride | HMDB | | Carbocaïne | HMDB | | Isocaine | HMDB | | Mepivacain-injektopas | HMDB | | Mepivacaine monohydrochloride | HMDB | | Scandicain | HMDB | | Scandonest | HMDB |
|
|---|
| Chemical Formula | C15H22N2O |
|---|
| Average Molecular Weight | 246.348 |
|---|
| Monoisotopic Molecular Weight | 246.173213336 |
|---|
| IUPAC Name | N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide |
|---|
| Traditional Name | mepivacaine |
|---|
| CAS Registry Number | 96-88-8 |
|---|
| SMILES | CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C |
|---|
| InChI Identifier | InChI=1S/C15H22N2O/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18) |
|---|
| InChI Key | INWLQCZOYSRPNW-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as piperidinecarboxamides. Piperidinecarboxamides are compounds containing a piperidine ring substituted with a carboxamide functional group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Piperidines |
|---|
| Sub Class | Piperidinecarboxylic acids and derivatives |
|---|
| Direct Parent | Piperidinecarboxamides |
|---|
| Alternative Parents | |
|---|
| Substituents | - 2-piperidinecarboxamide
- Piperidinecarboxamide
- M-xylene
- Xylene
- Monocyclic benzene moiety
- Benzenoid
- Tertiary aliphatic amine
- Tertiary amine
- Carboximidic acid
- Carboximidic acid derivative
- Azacycle
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Amine
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 150.5 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.62 g/L | Not Available | | LogP | 2.2 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.32 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.9823 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.62 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 138.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Mepivacaine,1TMS,isomer #1 | CC1=CC=CC(C)=C1N(C(=O)C1CCCCN1C)[Si](C)(C)C | 1955.5 | Semi standard non polar | 33892256 | | Mepivacaine,1TMS,isomer #1 | CC1=CC=CC(C)=C1N(C(=O)C1CCCCN1C)[Si](C)(C)C | 1933.7 | Standard non polar | 33892256 | | Mepivacaine,1TMS,isomer #1 | CC1=CC=CC(C)=C1N(C(=O)C1CCCCN1C)[Si](C)(C)C | 2507.0 | Standard polar | 33892256 | | Mepivacaine,1TBDMS,isomer #1 | CC1=CC=CC(C)=C1N(C(=O)C1CCCCN1C)[Si](C)(C)C(C)(C)C | 2174.2 | Semi standard non polar | 33892256 | | Mepivacaine,1TBDMS,isomer #1 | CC1=CC=CC(C)=C1N(C(=O)C1CCCCN1C)[Si](C)(C)C(C)(C)C | 2149.2 | Standard non polar | 33892256 | | Mepivacaine,1TBDMS,isomer #1 | CC1=CC=CC(C)=C1N(C(=O)C1CCCCN1C)[Si](C)(C)C(C)(C)C | 2627.4 | Standard polar | 33892256 |
|
|---|